1.Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis.
Jun-ming LI ; Na LI ; Dao-yin ZHU ; La-gen WAN ; Yong-lin HE ; Chun YANG
Chinese Medical Journal 2008;121(12):1114-1119
BACKGROUNDIsocitrate lyase (ICL) was previously demonstrated to play a pivotal role in the intracellular metabolism of Mycobacterium tuberculosis (MTB). Presently several lines of evidence suggest that ICL from MTB (MTB-ICL) may play some roles in the interaction between MTB and host macrophage. However, there has been no research on the interaction between MTB-ICL and host macrophage.
METHODSMTB-icl and M. smegmatis (MS)-icl genes were amplified by polymerase chain reaction (PCR) and cloned into the E. coli-mycobacterium shuttle plasmid pUV15 to obtain recombinant shuttle plasmids pMTB-icl and pMS-icl. Following transformation into MS by electroporation, the expression of pMTB-icl and pMS-icl was verified by reverse transcriptase (RT)-PCR. The expression of recombinant plasmids derived from pUV15 when rMS was phagocytized by macrophage was also verified via fluorescence microscope. Ms 1 - 2c, rMS-pUV15, rMS-pMS-icl and rMS-pMTB-icl were used to infect RAW264.7 cells and the survival of intracellular MS was monitored by bacterial culture at 0, 24 and 48 hours after infection. The culture supernatants from macrophage infected by Ms 1 - 2c, rMS-pUV15, rMS-pMS-icl and rMS-pMTB-icl were collected and the interferon (IFN)-gamma and nitric oxide (NO) concentrations were measured by ELISA or by Griess assay, respectively. The apoptosis of macrophage was assayed by the in situ TUNEL technique.
RESULTSRT-PCR showed that both pMTB-icl and pMS-icl could be expressed in MS. Fluorescence microscopic observation showed that recombinant plasmids derived from pUV15 (pUV15-IG) could also be expressed in MS when MS were phagocytized by macrophage. Bacterial culture data demonstrated that rMS-pMTB-icl exhibited significantly increased intracellular survival in the murine macrophage cell line RAW264.7 compared with Ms 1 - 2c, rMS-pUV15 and rMS-pMS-icl. This increased intracellular survival was not accompanied by the upregulation of IFN-gamma and NO in host macrophage. But a lower apoptosis rate of macrophages infected with rMS-pMTB-icl was observed when compared with macrophages infected with other strains of MS.
CONCLUSIONSMTB-ICL could promote the intracellular survival of MS. Suppressing the apoptosis of host macrophage may be one of the important mechanisms involved in this increased intracellular survival.
Animals ; Apoptosis ; genetics ; physiology ; Cell Line ; In Situ Nick-End Labeling ; Interferon-gamma ; metabolism ; Isocitrate Lyase ; genetics ; metabolism ; Macrophages ; cytology ; metabolism ; microbiology ; Microbial Viability ; Microscopy, Fluorescence ; Mycobacterium smegmatis ; enzymology ; genetics ; growth & development ; Mycobacterium tuberculosis ; enzymology ; genetics ; Nitric Oxide ; metabolism ; Plasmids ; genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Transformation, Genetic
2.Corn silk induces nitric oxide synthase in murine macrophages.
Kyung A KIM ; Sang Kyu CHOI ; Hye Seon CHOI
Experimental & Molecular Medicine 2004;36(6):545-550
Corn silk has been purified as an anticoagulant previously and the active component is a polysaccharide with a molecular mass of 135 kDa. It activates murine macrophages to induce nitric oxide synthase (NOS) and generate substantial amounts of NO in time and dose-dependent manners. It was detectable first at 15 h after stimulation by corn silk, peaked at 24 h, and undetectable by 48 h. Induction of NOS is inhibited by pyrolidine dithiocarbamate (PDTC) and genistein, an inhibitor of nuclear factor kappa B (NF-kappaB) and tyrosine kinase, respectively, indicating that iNOS stimulated by corn silk is associated with tyrosine kinase and NF-kappaB signaling pathways. IkappaB-alpha degradation was detectible at 10 min, and the level was restored at 120 min after treatment of corn silk. Corn silk induced nuclear translocation of NF-kappaB by phosphorylation and degradation of IkappaB-alpha.
Animals
;
Anticoagulants/*pharmacology
;
Genistein/pharmacology
;
I-kappa B/metabolism
;
Macrophages/drug effects/*enzymology/metabolism
;
Mice
;
NF-kappa B/antagonists & inhibitors/metabolism
;
Nitric Oxide/biosynthesis
;
Nitric-Oxide Synthase/antagonists & inhibitors/*biosynthesis
;
Phosphorylation
;
Plant Extracts/pharmacology
;
Polysaccharides/*pharmacology
;
Protein Transport/drug effects
;
Protein-Tyrosine Kinase/antagonists & inhibitors/physiology
;
Pyrrolidines/pharmacology
;
Research Support, Non-U.S. Gov't
;
Thiocarbamates/pharmacology
;
Zea mays/*chemistry
3.Induction of nitric oxid esynthase(NOS) by soluble glucocorticoid induced tumor necrosis factor receptor(sGITR) is modulated by IFN-g in murine macrophage.
Hyun Hee SHIN ; Hyeon Woo LEE ; Hye Seon CHOI
Experimental & Molecular Medicine 2003;35(3):175-180
Earlier study showed that glucocorticoid induced tumor necrosis factor receptor (GITR), a new TNFR family, activated murine macrophages to express inducible nitric oxide synthase (iNOS) and to generate nitric oxide (NO). A possible involvement of pro-inflammatory cytokines on NO production by GITR was investigated in vitro systems and signaling molecules contributing to sGITR-induced iNOS production are determined in Raw 264.7 cells, a murine macrophage cell line. The result showed that the synergy was afforded by the combination of GITR with IFN-gamma in a dose-dependent manner but IFN-gamma alone was not able to induce NOS. No effects were observed with TNF-alpha, IL-1beta, or IL-6 co-treated with GITR. To determine signaling molecules contributing to sGITR-induced iNOS production, a specific inhibitor for signal pathway proteins tested showed that PDTC (NF- kB) and genistein (tyrosine kinase) inhibited NOS induction significantly, while sodium orthovanadate (tyrosine phosphatase) potentiated NOS expression. These results suggest that activations of NF-kB were involved in induction of iNOS by GITR and IFN-gamma priming caused earlier and stronger NF-kB activation.
Animals
;
Cells, Cultured
;
Cytokines/*metabolism
;
Enzyme Induction
;
Interferon Type II/pharmacology
;
Macrophages/*enzymology/physiology
;
Mice
;
NF-kappa B/metabolism
;
Nitric Oxide/metabolism
;
Nitric-Oxide Synthase/*biosynthesis
;
Protein-Tyrosine Kinase/metabolism
;
Protein-Tyrosine-Phosphatase/metabolism
;
Receptors, Nerve Growth Factor/*metabolism
;
Receptors, Tumor Necrosis Factor/*metabolism
4.Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.
Sang Eun KIM ; Tran Thi THUY ; Ji Hyun LEE ; Jai Youl RO ; Young An BAE ; Yoon KONG ; Jee Yin AHN ; Dong Soon LEE ; Yeon Mock OH ; Sang Do LEE ; Yun Song LEE
Experimental & Molecular Medicine 2009;41(4):277-287
Matrix metalloproteinase-9 (MMP-9) may play an important role in emphysematous change in chronic obstructive pulmonary disease (COPD), one of the leading causes of mortality and morbidity worldwide. We previously reported that simvastatin, an inhibitor of HMG-CoA reductase, attenuates emphysematous change and MMP-9 induction in the lungs of rats exposed to cigarette smoke. However, it remained uncertain how cigarette smoke induced MMP-9 and how simvastatin inhibited cigarette smoke-induced MMP-9 expression in alveolar macrophages (AMs), a major source of MMP-9 in the lungs of COPD patients. Presently, we examined the related signaling for MMP-9 induction and the inhibitory mechanism of simvastatin on MMP-9 induction in AMs exposed to cigarette smoke extract (CSE). In isolated rat AMs, CSE induced MMP-9 expression and phosphorylation of ERK and Akt. A chemical inhibitor of MEK1/2 or PI3K reduced phosphorylation of ERK or Akt, respectively, and also inhibited CSE-mediated MMP-9 induction. Simvastatin reduced CSE-mediated MMP-9 induction, and simvastatin-mediated inhibition was reversed by farnesyl pyrophosphate (FPP) or geranylgeranyl pyrophosphate (GGPP). Similar to simvastatin, inhibition of FPP transferase or GGPP transferase suppressed CSE-mediated MMP-9 induction. Simvastatin attenuated CSE-mediated activation of RAS and phosphorylation of ERK, Akt, p65, IkappaB, and nuclear AP-1 or NF-kappaB activity. Taken together, these results suggest that simvastatin may inhibit CSE-mediated MMP-9 induction, primarily by blocking prenylation of RAS in the signaling pathways, in which Raf-MEK-ERK, PI3K/Akt, AP-1, and IkappaB-NF-kappaB are involved.
1-Phosphatidylinositol 3-Kinase/metabolism
;
Alkyl and Aryl Transferases/metabolism
;
Animals
;
Anticholesteremic Agents/pharmacology
;
Cells, Cultured
;
Enzyme Inhibitors/metabolism/pharmacology
;
Extracellular Signal-Regulated MAP Kinases/metabolism
;
Gene Expression Regulation, Enzymologic/*drug effects
;
I-kappa B Kinase/antagonists & inhibitors/metabolism
;
Macrophages, Alveolar/cytology/*drug effects/*enzymology
;
Matrix Metalloproteinase 9/genetics/*metabolism
;
Mitogen-Activated Protein Kinase Kinases/metabolism
;
Polyisoprenyl Phosphates/metabolism
;
Proto-Oncogene Proteins c-akt/metabolism
;
Rats
;
Sesquiterpenes/metabolism
;
Signal Transduction/physiology
;
Simvastatin/*pharmacology
;
Smoke/*adverse effects
;
*Tobacco/adverse effects/chemistry